References

ABS (Australian Bureau of Statistics) 2006. Statistical geography: volume 1—Australian Standard Geographical Classification (ASGC). ABS cat. no. 1216.0. Canberra: ABS.

ABS 2011. Australian Standard Classification of Drugs of Concern, 2011. ABS cat. no. 1248.0. Canberra: ABS.

ABS 2016a. Estimates of Aboriginal and Torres Strait Islander Australians, July 2016. ABS cat. no.1270.0.55.005. Canberra: ABS.

ABS 2016b. Australian Statistical Geography Standard (ASGS): volume 5—remoteness structure, July 2011. ABS cat. no. 1270.0.55.005. Canberra: ABS.

ABS 2017. Migration, Australia, 2015–16. ABS cat. no. 3412.0. Canberra: ABS.

ABS 2019a. Estimates and Projections, Aboriginal and Torres Strait Islander Australians, 2006 to 2031. ABS cat. no. 3238.0. Canberra: ABS.

ABS 2019b. Migration, Australia, 2017–18. ABS cat. no. 3412.0. Canberra: ABS.

ADCA (Alcohol and other Drugs Council of Australia) 2013. Tips and tricks for new players: a guide to becoming familiar with the alcohol and other drugs sector. Canberra: ADCA.

ADF (Australian Drug Foundation) 2013. Fact sheet: benzodiazepine facts. Melbourne: ADF.

ADF 2020. Opioids. Viewed 25 February 2020.

AIHW (Australian Institute of Health and Welfare) 2011. Drugs in Australia 2010: tobacco, alcohol and other drugs. Drug statistics series no. 27. Cat. no. PHE 154. Canberra: AIHW.

AIHW 2015. Trends in methylamphetamine availability, use and treatment 2003–04 to 2013‍–‍14. Drug treatment series no. 26. Cat. no. HSE 165. Canberra: AIHW.

AIHW 2019. Australian Burden of Disease Study 2015: Interactive data on risk factor burden. Cat. no. BOD 22. Canberra: AIHW. Viewed 17 June 2019.

AIHW 2020. National Drug Strategy Household Survey 2019: detailed findings. Drug Statistics series no. 32. Cat. no. PHE 270. Canberra: AIHW.

AIHW 2021. National opioid pharmacotherapy statistics (NOPSAD) 2020. Cat. no. PHE 266. Canberra: AIHW. Canberra: AIHW.

COAG (Council of Australian Governments) 2012. National Healthcare Agreement. Canberra: COAG. Viewed 23 March 2016.

Degenhardt L, Sara G, McKetin R, Roxburgh A, Dobbins T, Farrell M et al. 2017. Crystalline methamphetamine use and methamphetamine-related harms in Australia. Drug and Alcohol Review 36:160–70.

Department of Health 2019. National Framework for Alcohol, Tobacco and Other Drug Treatment 2019–29. Canberra: Department of Health. Viewed 23 April 2021.

DSS (Department of Social Services) 2020. National Housing and Homelessness Agreement. Canberra: DSS. Viewed 1 July 2020

Lee N, Johns L, Jenkinson R, Johnston J, Connolly K, Hall K et al. 2007. Clinical treatment guidelines for alcohol and drug clinicians. No. 14: methamphetamine dependence and treatment. Melbourne: Turning Point Alcohol and Drug Centre Inc.

Man N, Chrzanowska A, Price O, Bruno R, Dietze PM, Sisson SA, et al. 2021. Trends in cocaine use, markets and harms in Australia, 2003–2019. Drug and Alcohol Review

Manning M, Smith C & Mazerolle P. 2013. The societal costs of alcohol misuse in Australia. Trends & issues in crime and criminal justice No. 454. Canberra: Australian Institute of Criminology. Viewed 4 April 2018.

McKetin R, Chrzanowska A, Man N, Peacock A, Sutherland R & Degenhardt L. 2021. Trends in treatment episodes for methamphetamine smoking and injecting in Australia, 2003–2019. Drug and Alcohol Review.

MCDS (Ministerial Council on Drug Strategy) 2011. National Drug Strategy 2010–2015. Canberra: Commonwealth of Australia.

NCPIC (National Cannabis Prevention and Information Centre) 2011. What is cannabis? Sydney: NCPIC.

NDARC (National Drug and Alcohol Research Centre) 2010. Alcohol fact sheet. Sydney: NDARC.

NDARC (National Drug and Alcohol Research Centre) Australian Drug Trends 2020: Key findings from the National Illicit Drug Reporting System Interviews. Sydney: National Drug and Alcohol Research Centre, UNSW Australia.

NDSC (National Drug Strategy Committee) 2017. National Drug Strategy 2017–2026. Canberra: Commonwealth of Australia.

NHMRC (National Health and Medical Research Council) 2009. Australian guidelines to reduce health risks from drinking alcohol. Canberra: Commonwealth of Australia.

O’Brien S 2004. Treatment options for heroin and other opioid dependence: a guide for families and carers. Canberra: Department of Health and Ageing.

Vanderplaschen W, Wolf J, Rapp R & Broekaert E 2007. Effectiveness of different models of case management for substance-abusing populations. Journal of Psychoactive Drugs 39(1):81–5.

Whetton S, Shanahan M, Cartwright K, Duraisingam V, Ferrante A, Gray D, Kaye S, Kostadinov V, McKetin R, Pidd K, Roche A, Tait R, Allsop S 2016. The social costs of methamphetamine in Australia 2013/14. National Drug Research Institute, Curtin University, Perth, Western Australia.

Whetton S, Tait R, Scollo M, Banks E, Chapman J, Dey T, Abdul Halim S, Makate M, McEntee A, Muhktar A, Norman R, Pidd K 2019. Identifying the Social Costs of Tobacco Use to Australia in 2015/16. National Drug Research Institute, Curtin University, Perth, Western Australia. Viewed 22 October 2019.

Whetton S, Tait R, Chrzanowka A, Donnelly N, McEntee, Muhktar A, et al. 2020. Quantifying the social costs of pharmaceutical opioid misuse & illicit opioid use to Australia in 2015/16. National Drug Research Institute, Curtin University, Perth, Western Australia.